Logo
x

Search

Subscribe Now

amd

Disease of the Month: Age-Related Macular Degeneration

Disease of the Month: Age-Related Macular Degeneration

  • February 9, 2023
Novartis Reports One Year Results of Beovu (brolucizumabin) in P- III MERLIN Study to Treat Wet Age-Related Macular Degeneration

Novartis Reports One Year Results of Beovu (brolucizumabin) in P- III MERLIN Study to Treat Wet Age-Related Macular Degeneration

  • May 31, 2021
BlueRock Collaborates with Fujifilm and Opsis to Discover and Develop Cell Therapies for Eye Diseases

BlueRock Collaborates with Fujifilm and Opsis to Discover and Develop Cell Therapies for Eye Diseases

  • May 18, 2021
Novartis Reports FDA's Acceptance of BLA for Brolucizumab (RTH258) to Treat Wet AMD

Novartis Reports FDA's Acceptance of BLA for Brolucizumab (RTH258) to Treat Wet AMD

  • April 16, 2019
Thea and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD

Thea and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD

  • March 19, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.